Since its inception in 1980, the Sidney Kimmel Comprehensive Cancer Center (SKCCC) Flow Cytometry Shared Resource has continuously offered state-of-the art cell sorting and analysis capabilities to the members of the SKCCC. These services are provided in a timely, flexible and affordable manner to Cancer Center members from across the entire medical campus. The resources provided by the Flow Core are not a duplication of those available elsewhere, and range from basic two color analyses, to complex sorting experiments involving up to 14 colors and 16 discrete parameters. Since the last renewal, the Flow Core has undergone the most dramatic update in its history. Specifically, the Core has acquired several new instruments, including two new high-end sorters. Both of these are high-speed, 14 color / 16 parameter Facs Aria units. The second unit is housed in a custom BSL-3 BioPROtect 111 Bio-Containment Enclosure, permitting users to sort un-fixed human cells under applicable CDC guidelines. The Core has also been relocated to a new, custom-designed physical space, a 1400 square ft. suite of three rooms on the fourth floor of the SKCCC Cancer Research Building (CRBI). Also, a new analysis unit, a special order research platform (SORP) LSR-II, with enhanced flow rates and detection capabilities has been added. Perhaps most significantly, two new experienced and dedicated personnel have been hired. Ms. Ada Tam serves as the Resource Manager;and Mr. Richard (Lee) Blosser who serves as co-manager and training Director. Their respective roles will be further detailed below. However, it should be noted that the Core now has the resources to provide training on each of the analysis units, cell sorting services, as well as back-end analysis assistance. Lay: Flow cytometry, is a method of sorting and measuring types of cells by fluorescent labeling of markers on the surface of the cells. It is sometimes referred to as FACS (Fluorescent Activated Cell Sorting) analysis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006973-51
Application #
8661008
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
51
Fiscal Year
2014
Total Cost
$173,195
Indirect Cost
$66,501
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Giraldo, Nicolas A; Nguyen, Peter; Engle, Elizabeth L et al. (2018) Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab. J Immunother Cancer 6:99
Barberi, Theresa; Martin, Allison; Suresh, Rahul et al. (2018) Absence of host NF-?B p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization. Cancer Immunol Immunother 67:1491-1503
Taube, Janis M; Galon, Jérôme; Sholl, Lynette M et al. (2018) Implications of the tumor immune microenvironment for staging and therapeutics. Mod Pathol 31:214-234
Krueger, Timothy E G; Thorek, Daniel L J; Denmeade, Samuel R et al. (2018) Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise. Stem Cells Transl Med 7:651-663
Boudadi, Karim; Suzman, Daniel L; Anagnostou, Valsamo et al. (2018) Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer. Oncotarget 9:28561-28571
Dean, Lorraine T; Gehlert, Sarah; Neuhouser, Marian L et al. (2018) Social factors matter in cancer risk and survivorship. Cancer Causes Control 29:611-618
Yuan, Ming; Da Silva, Ana Cristina A L; Arnold, Antje et al. (2018) MicroRNA (miR) 125b regulates cell growth and invasion in pediatric low grade glioma. Sci Rep 8:12506
Jacobs, Michael A; Macura, Katarzyna J; Zaheer, Atif et al. (2018) Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors. Acad Radiol 25:1405-1414
Annesley, Colleen E; Rabik, Cara; Duffield, Amy S et al. (2018) Knock-in of the Wt1 R394W mutation causes MDS and cooperates with Flt3/ITD to drive aggressive myeloid neoplasms in mice. Oncotarget 9:35313-35326
Liu, Tao; Ivaturi, Vijay; Sabato, Philip et al. (2018) Sorafenib Dose Recommendation in Acute Myeloid Leukemia Based on Exposure-FLT3 Relationship. Clin Transl Sci 11:435-443

Showing the most recent 10 out of 2393 publications